Molecular imaging market to reach $400M in 2014
MOUNTAIN VIEW, CA--Photonics market-research firm Strategies Unlimited says that in-vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI.
MOUNTAIN VIEW, CA--Photonics market-research firm Strategies Unlimited says that in-vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade. However, this strong growth hinges on partnerships with key medical equipment vendors, the outcomes of clinical trials assessing imaging agents, regulatory approvals, patent litigation, and decisions about insurance reimbursement.
Optical molecular imaging is an attractive and cost-effective tool for examining and monitoring disease states and to determine a drug's effectiveness in living tissue. Highly portable, fast, and less expensive than conventional imaging technologies, it has the potential to bring sophisticated diagnostics right to the doctor's office. When coupled with more traditional imaging tools such as CT and MRI, optical imaging adds an unprecedented degree of quantification and specificity to the healthcare decision-making process.
Strategies Unlimited says the market will likely expand in two complementary directions: research systems and clinical systems. The research market will continue at a steady pace as OMI approaches become more widely used for drug discovery and preclinical studies. Recent advances in imaging agents will power the transition of optical techniques from the lab to clinical settings. Cameras and optical filters will also be integral components of the clinical devices.
Large imaging firms, such as GE Healthcare, Siemens, and Philips, are beginning to pursue optical molecular imaging, while over 12 companies are already marketing OMI systems.
Optical Molecular Imaging 2010: Technology, Applications, and Markets is the first report to cover this emerging segment of optical imaging systems. It discusses the market opportunities, technology trends, leading system vendors, and key factors that will influence the market. Strategies Unlimited has a reputation for providing deep and trustworthy reporting on complex markets, and the report draws heavily on extensive interviews with experts in the field. Other recent reports by Strategies Unlimited cover Optical Coherence Tomography (OCT), image sensors, laser applications, and LED lighting systems.
For more information, contact Strategies Unlimited at +1 650-941–3438 (voice) or e-mail at email@example.com, or check the company's web site at www.strategies-u.com.
Optoelectronics Report (ISSN 1522-2837) encourages the submission of news, views, and comments about your company and the industry. Sales reports, market outlooks, strategic moves, and personnel changes are just a few of the kinds of items we would like you to share with our readers. Please fax information to Gail Overton at (603) 891-0574 or send e-mail to firstname.lastname@example.org.
Optoelectronics Report © 2010 is published 24 times a year by PennWell Corp., Advanced Technology Division, Communications and Optoelectronics Group, 98 Spit Brook Road, Nashua, NH 03062, for executives and marketers, highlighting business news and technology trends in the optoelectronics industry. An annual e-mail subscription to Optoelectronics Report, prepaid, is $315 worldwide. The annual Economic Review and Forecast, published in January, is available with the data on disk for $250. All other back issues are $15. All rights reserved. Use of this publication must be in compliance with the law. Optoelectronics Report is protected under international copyright laws and may not be reproduced without special permission of the publisher. Requests for subscription or bulk orders should be sent to Customer Service, 98 Spit Brook Road, Nashua, NH 03062; tel.: (603) 891-9416, FAX: (603) 891-9350.